Wednesday, July 8, 2026

Patent intelligence · US

US 11970554

Labeled oxytocin and method of manufacture and use

granted A61KA61K51/084
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 18
Applicant portfolio 86
Patent details — US 11970554

Quick answer

US 11970554 (Labeled oxytocin and method of manufacture and use) is held by TONIX PHARMACEUTICALS HOLDING CORP. Status: granted. Granted Apr 30, 2024. Expires Apr 25, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
5
CPC classes
A61K, A61K51/084

More from TONIX PHARMACEUTICALS HOLDING CORP

Related pharmaceutical patents in our USPTO index.

  1. US 12383733

    Iontophoresis-based patch type medicine absorption device

    ROOTONIX Co., Ltd. · Expires Aug 7, 2045

    granted
  2. US 12365879

    Synthetic chimeric poxviruses

    TONIX PHARMA LIMITED · Expires Jul 17, 2045

    granted
  3. US 12304901

    Selective ligands for tau aggregates

    Sentonix, Inc. · Expires May 15, 2045

    granted
  4. US 12156897

    Magnesium-containing oxytocin formulations and methods of use

    TONIX PHARMA LIMITED · Expires Nov 28, 2044

    granted
  5. US 12156864

    Analogs of cyclobenzaprine and amitryptilene

    TONIX PHARMACEUTICALS HOLDING CORP · Expires Nov 28, 2044

    granted
  6. US 12097183

    Pharmaceutical composition for treating migraine

    Tonix Medicines, Inc. · Expires Sep 19, 2044

    granted
  7. US 12090139

    Formulations comprising triptan compounds

    Tonix Medicines, Inc. · Expires Sep 12, 2044

    granted
  8. US 11998516

    Methods and compositions for treating depression using cyclobenzaprine

    TONIX PHARMA LIMITED · Expires May 30, 2044

    granted

Frequently asked questions

What is US patent 11970554?

US 11970554 (Labeled oxytocin and method of manufacture and use) is held by TONIX PHARMACEUTICALS HOLDING CORP. Status: granted. Granted Apr 30, 2024. Expires Apr 25, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 11970554?

TONIX PHARMACEUTICALS HOLDING CORP is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 86 pharmaceutical patents for this assignee.

When does US 11970554 expire?

Our index shows an expiration date of Apr 25, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.